Dermatitis News

Dermarta Therapeutics, LLC, has announced positive results from a 28-day phase 1 study of its lead compound, DMT210, in treating patients with rosacea.

The National Rosacea Society has awarded funding to three new and two ongoing studies, according to a press release.

Study findings that Mohs micrographic surgery was used effectively to treat melanoma in situ exceeding traditional excision margins of 5 mm was among the most-read articles in September on Healio.com/Dermatology.

Provider-based diagnosis data yielded an association between food allergy and the development of respiratory allergy, along with lower rates of eczema and higher rates of asthma than previously reported, according to published findings.

ORLANDO, Fla. — Marked increases in CV risk factors and HF incidence were common in patients with polymyositis and dermatomyositis, according to a poster presentation from the Heart Failure Society of America Scientific Assembly.

Researchers at the Icahn School of Medicine at Mount Sinai and Northwestern University’s Feinberg School of Medicine have identified the skin phenotype of atopic dermatitis in infants, according to a press release.

Survey results finding that children with eczema have been bullied and have lower self-esteem was among the most-read developments reported on Healio.com/Dermatology.

Study findings that platelet-rich plasma did not significantly improve female androgenetic alopecia was among the most-read articles of the past week on Healio.com/Dermatology and Healio.com/Aesthetics.

Children aged 6 to 11 years generally only need to bathe two or three times per week, with less bathing possibly building stronger immune systems, according Robert Sidbury, MD, MPH, FAAD, associate professor, department of pediatrics and division chief of dermatology, at the University of Washington School of Medicine.

Allergan plc announced today it has entered into a definitive agreement to acquire Vitae Pharmaceuticals for $21 per share in cash, for a total value of approximately $639 million.